SIRT1 and neoplasm: Lastly, pharmacological inhibition of NAD+ and Sirt1 leads to direct inhibition of Klf2 and Ccr7, thus confirming that the NAD+-Sirt1 axis regulates differentiation, migration, effector functions and the anti-tumor response of Th1/17 cells (29).